PIK3CA and breast carcinoma: We determined the relevant variables that affect downstream MAPK and PI3K signaling and presented a unified model that enabled us to assess the effect of single and combination treatments and to predict the resulting proliferative behavior in cell lines representing three subtypes of breast cancer.